Cargando…

Continuous Glucose Monitoring in Patients With Type 1 Diabetes Using Insulin Injections

Detalles Bibliográficos
Autores principales:	Foster, Nicole C., Miller, Kellee M., Tamborlane, William V., Bergenstal, Richard M., Beck, Roy W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Diabetes Association 2016
Materias:	e-Letters: Observations
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5317243/ https://www.ncbi.nlm.nih.gov/pubmed/27208319 http://dx.doi.org/10.2337/dc16-0207

Ejemplares similares

No Summer Vacation From Diabetes: Glycemic Control in Pediatric Participants in the T1D Exchange Registry Based on Time of Year
por: Sherr, Jennifer L., et al.
Publicado: (2016)

Treatable Diabetic Retinopathy Is Extremely Rare Among Pediatric T1D Exchange Clinic Registry Participants
por: Beauchamp, Giovanna, et al.
Publicado: (2016)

Effect of Lipohypertrophy on Accuracy of Continuous Glucose Monitoring in Patients With Type 1 Diabetes
por: DeSalvo, Daniel J., et al.
Publicado: (2015)

Trends in Insulin Use and Diabetes Control in the U.S.: 1988–1994 and 1999–2012
por: Selvin, Elizabeth, et al.
Publicado: (2016)

Continuous Glucose Monitoring in the Operating Room and Cardiac Intensive Care Unit
por: Perez-Guzman, M. Citlalli, et al.
Publicado: (2021)

Lessons From Continuous Glucose Monitoring in Youth With Pre–Type 1 Diabetes, Obesity, and Cystic Fibrosis
por: Chan, Christine L., et al.
Publicado: (2020)

Use of Adjuvant Pharmacotherapy in Type 1 Diabetes: International Comparison of 49,996 Individuals in the Prospective Diabetes Follow-up and T1D Exchange Registries
por: Lyons, Sarah K., et al.
Publicado: (2017)

Extended 6-Month Follow-Up of A Randomized Clinical Trial to Assess the Efficacy and Safety of Real-Time Continuous Glucose Monitoring in the Management of Type 1 Diabetes in Young Children Aged 4 to <10 Years
por: Tansey, Michael, et al.
Publicado: (2013)

Real-time Continuous Glucose Monitoring During a Hyperinsulinemic-Hypoglycemic Clamp Significantly Underestimates the Degree of Hypoglycemia
por: Farrell, Catriona M., et al.
Publicado: (2020)

Continuous Glucose Sensor Survival and Accuracy Over 14 Consecutive Days
por: DeSalvo, Daniel J., et al.
Publicado: (2016)

Response to Comment on Bergenstal et al. Glucose Management Indicator (GMI): A New Term for Estimating A1C From Continuous Glucose Monitoring. Diabetes Care 2018;41:2275–2280
por: Bergenstal, Richard M., et al.
Publicado: (2019)

Acute Effect of Empagliflozin on Fractional Excretion of Sodium and eGFR in Youth With Type 2 Diabetes
por: Bjornstad, Petter, et al.
Publicado: (2018)

Food Order Has a Significant Impact on Postprandial Glucose and Insulin Levels
por: Shukla, Alpana P., et al.
Publicado: (2015)

Management of Diabetic Ketoacidosis in Severe Insulin Resistance
por: Robinson, Cemre, et al.
Publicado: (2016)

Feasibility and Acceptability of Using Flash Glucose Monitoring System Sensors to Empower Lifestyle Changes in People With Prediabetes
por: Lee, Joyce Y., et al.
Publicado: (2023)

The Effect of the Menstrual Cycle on Glucose Control in Women With Type 1 Diabetes Evaluated Using a Continuous Glucose Monitoring System
por: Barata, Denise S., et al.
Publicado: (2013)

Periprocedural Euglycemic Diabetic Ketoacidosis Associated With Sodium–Glucose Cotransporter 2 Inhibitor Therapy During Colonoscopy
por: Meyer, Emily J., et al.
Publicado: (2020)

Feasibility of Outpatient 24-Hour Closed-Loop Insulin Delivery
por: de Bock, Martin I., et al.
Publicado: (2015)

Advanced Technology in the Management of Diabetes: Which Comes First—Continuous Glucose Monitor or Insulin Pump?
por: Martin, Christopher T., et al.
Publicado: (2019)

Sodium–Glucose Cotransporter 2 Inhibitors and Diabetic Ketoacidosis: A Case Series From Three Academic Institutions
por: Misaghian-Xanthos, Negin, et al.
Publicado: (2017)

Effect of Acetaminophen on CGM Glucose in an Outpatient Setting
por: Maahs, David M., et al.
Publicado: (2015)

An Insulin Resistance Score Improved Diabetes Risk Assessment in the Malmö Prevention Project—A Longitudinal Population-Based Study of Older Europeans
por: Shiffman, Dov, et al.
Publicado: (2021)

Insulin Resistance and Risk of Major Vascular Events and All-Cause Mortality in Type 1 Diabetes: A 10-Year Follow-up Study
por: Garofolo, Monia, et al.
Publicado: (2020)

HbA(1c), Insulin Resistance, and β-Cell Function in Relation to Cognitive Function in Type 2 Diabetes: The CAROLINA Cognition Substudy
por: Janssen, Jolien, et al.
Publicado: (2019)

Use of Metformin and Cardiovascular Effects of New Classes of Glucose-Lowering Agents: A Meta-analysis of Cardiovascular Outcome Trials in Type 2 Diabetes
por: Zaccardi, Francesco, et al.
Publicado: (2021)

Predictive Value of Admission Hemoglobin A(1c) on Inpatient Glycemic Control and Response to Insulin Therapy in Medicine and Surgery Patients With Type 2 Diabetes
por: Pasquel, Francisco J., et al.
Publicado: (2015)

Simultaneous Consideration of HbA(1c) and Insulin Resistance Improves Risk Assessment in White Individuals at Increased Risk for Future Type 2 Diabetes
por: Meigs, James B., et al.
Publicado: (2020)

Impact of Higher Insulin Prices on Out-of-Pocket Costs in Medicare Part D
por: Tseng, Chien-Wen, et al.
Publicado: (2020)

Role of Noninsulin Therapies Alone or in Combination in Chromosome 6q24-Related Transient Neonatal Diabetes: Sulfonylurea Improves but Does Not Always Normalize Insulin Secretion
por: Carmody, David, et al.
Publicado: (2015)

Performance of the Insulin-Only iLet Bionic Pancreas and the Bihormonal iLet Using Dasiglucagon in Adults With Type 1 Diabetes in a Home-Use Setting
por: Castellanos, Luz E., et al.
Publicado: (2021)

Creating Composite Indices From Continuous Variables for Research: The Geometric Mean
por: Gerstein, Hertzel C., et al.
Publicado: (2021)

The Effect of Discontinuing Continuous Glucose Monitoring in Adults With Type 2 Diabetes Treated With Basal Insulin
por: Aleppo, Grazia, et al.
Publicado: (2021)

Swimming With the Omnipod 5 Automated Insulin Delivery System: Connectivity in the Water
por: Hughes, Michael S., et al.
Publicado: (2023)

Response to Comment on Rickels et al. Intranasal Glucagon for Treatment of Insulin-Induced Hypoglycemia in Adults With Type 1 Diabetes: A Randomized Crossover Noninferiority Study. Diabetes Care 2016;39:264–270
por: Rickels, Michael R., et al.
Publicado: (2016)

Hypoglycemic Event Frequency and the Effect of Continuous Glucose Monitoring in Adults with Type 1 Diabetes Using Multiple Daily Insulin Injections
por: Riddlesworth, Tonya, et al.
Publicado: (2017)

Subjects With Extreme-Duration Type 1 Diabetes Exhibit No Structural or Functional Abnormality on Cardiac MRI
por: Asghar, Omar, et al.
Publicado: (2016)

Diabetes Presentation in Infancy: High Risk of Diabetic Ketoacidosis
por: Letourneau, Lisa R., et al.
Publicado: (2017)

Out of Pocket Diabetes-Related Medical Expenses for Adolescents and Young Adults With Type 1 Diabetes: The SEARCH for Diabetes in Youth Study
por: Merjaneh, Lina, et al.
Publicado: (2019)

Economic Evaluation of the $35 Insulin Copay Cap Policy in Medicare and Its Implication for Future Interventions
por: Shao, Hui, et al.
Publicado: (2022)

Use of Complementary and Alternative Medicine in Older Adults With Diabetes
por: Rhee, Taeho Greg, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_culcb872ahppjut6c1inb5u234